Filter and sort all 500 stocks
Today's biggest gainers and losers
Visual sector performance
Turnstone Biologics Shifts Focus To 'High Unmet Medical Need' Cancers, Shares Initial Data From Colorectal Cancer Cell Therapy Study
Turnstone Biologics set to go public as upsized $80 million IPO pricing at low end of expected range